{{Rsnum
|rsid=7200749
|Gene=VKORC1
|Chromosome=16
|position=31091268
|Orientation=plus
|GMAF=0.05739
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=VKORC1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 1.8 | 98.2
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 4.8 | 38.1 | 57.1
| ASW | 8.8 | 35.1 | 56.1
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 10.9 | 30.0 | 59.1
| MEX | 0.0 | 0.0 | 0.0
| MKK | 9.6 | 39.1 | 51.3
| TSI | 0.0 | 1.0 | 99.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs7200749
|Name_s=VKORC1:3462C>T; 8773C>T
|Gene_s=VKORC1
|Feature=
|Evidence=PubMed ID:16270629
|Annotation=This SNP is the tagging SNP for VKORC1*3F (with 20% allele frequency in africans (AFR).
|Drugs=warfarin
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA162356244
}}

{{PMID Auto
|PMID=18855533
|Title=VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans.
|OA=1
}}

{{PMID Auto
|PMID=23691226
|Title=Novel associations of VKORC1 variants with higher acenocoumarol requirements.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}